Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme
- PMID: 34773801
- PMCID: PMC8503966
- DOI: 10.1016/j.diagmicrobio.2021.115561
Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme
Abstract
We report on sample IS/17575 since it generated highly divergent results in the Belgian SARS-CoV-2 serology external quality assessment scheme. Sample IS/17575 was serum originating from a 30 years old male patient. 124 diagnostic laboratories analysed this sample. A total of 168 results was returned (including 5 doubles). Overall, 38 were positive. All tests against S1 were positive except the Euroimmun IgG ELISA and the Ortho clinical Diagnostics VITROS IgG CLIA. All tests against S1/S2 (Liaison, Diasorin) resulted in a signal above cutoff. Assays against RBD, mostly generate a negative result. An exception are the Wantai SARS-CoV-2 ELISA's. All tests targeting N protein were negative. The survey shows, when >6 months post-infection, assays targeting at least S1, and preferably S1 combined with S2, are the most sensitive. This finding accentuates the necessity of external quality assessment schedules and importance of antigenic composition of serologic SARS-CoV-2 assays.
Keywords: Nucleocapsid protein; SARS-CoV-2; Spike protein; external quality assessment scheme; receptor-binding domain; serology.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The author stated that there are no conflicts of interest regarding the publication of this article.
Figures
References
-
- Acro biosystems. How does the COVID-19 antibody ELISA test function? 2021; Available at: https://www.acrobiosystems.com/A1125-How-does-the-COVID-19-antibody-ELIS.... Accessed February 22, 2021.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous